Hendrerit nec est egestas magna rhoncus semper urna volutpat vulputate gravida sit. Himenaeos pharetra porttitor enim suspendisse dictum proin praesent eu. Consequat per ligula tempor amet scelerisque pellentesque ac dictum.
Hendrerit nec est egestas magna rhoncus semper urna volutpat vulputate gravida sit. Himenaeos pharetra porttitor enim suspendisse dictum proin praesent eu. Consequat per ligula tempor amet scelerisque pellentesque ac dictum.
Hendrerit nec est egestas magna rhoncus semper urna volutpat vulputate gravida sit. Himenaeos pharetra porttitor enim suspendisse dictum proin praesent eu. Consequat per ligula tempor amet scelerisque pellentesque ac dictum.
Hendrerit nec est egestas magna rhoncus semper urna volutpat vulputate gravida sit. Himenaeos pharetra porttitor enim suspendisse dictum proin praesent eu. Consequat per ligula tempor amet scelerisque pellentesque ac dictum.
Sit si duis conubia
Nascetur diam aptent nullam
Taciti integer fames lobortis
Sit si duis conubia
Nascetur diam aptent nullam
Taciti integer fames lobortis
This is a 2 or 3 Column Feed
UKI2S joins Clean Growth Fund, advancing seed round total to £3 million. UKI2S is investing from its engineering biology portfolio and HutanBio joins its portfolio of high-impact companies.
Wave Photonics, a Cambridge-based deep tech start-up, has received £4.5M to develop on-chip photonics designs for quantum technologies, sensors, and datacentre applications.
UK-based technology startup Mirico has raised a successful funding round to support its distinctive laser-based sensing and data analytics platform, which is initially focused on finding and eliminating methane leaks from oil & gas infrastructure.
Managed by Future Planet Capital. As part of the UK government's ambitious 10-year vision for the Space Industry, where over £10 billion has been pledged to position the UK as a global leader, the UK Space Agency is...
To develop AI-driven sepsis and infection tests. UK start-up Presymptom Health has raised £1.5m in follow-on seed and grant funding that will help accelerate time to market of its AI-driven sepsis and infection tests...
ExactTrak, a leading player in UK cybersecurity who recently secured a UK Government contract, has successfully raised £1 million to fix a gap in cybersecurity...
HonuWorx uses ingenious tech to deliver zero-emission underwater operations...
To get AI-driven infection test into the NHS faster helping to tackle Anti-Microbial Resistance.
NetZero by 2030. Responsible investment. Environmental action. Social inclusion. Impact-first – that’s the mission. The…
By Douglas Hansen-Luke, Executive Chairman and Founder of Future Planet Capital (FPC) - Fund Manager of UKI2S
Supported by UK Ministry Of Defence contributed through UKI2S. Oxford Space Systems announces the successful completion of a £3 million equity investment...
Proving its X-ray diffraction technology (XRD) has the potential to enhance security, improve passenger facilitation, increase throughput, and reduce airport operational costs.
To Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases
Building sustainability with engineering biology and AI...
Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have impact across a wide range of applications...
Laverock Therapeutics to commercialise the gene editing induced gene silencing (GEiGS®) platform for all human therapeutic applications.
Machine Discovery, a software company which uses machine learning technology to accelerate compute-intensive optimisation and simulation tasks, has secured £4.5-million of funding...
The UK Innovation and Science Seed Fund (UKI2S), independently managed by Future Planet Capital (Ventures), is unleashing support...
The new start-up will harness an AI-first approach to develop eco-friendly alternatives to everyday ingredients…
Investments in HALO X-ray Technologies will support regulatory approval of the first fieldable XRD system in checkpoint security...
Investment in the UK Innovation & Science Seed Fund (UKI2S), a driving force in supporting early-stage innovation and high-impact businesses, now totals £102m.
Bacterial resistance to antibiotics is growing as a critical worldwide challenge, often stated as the…
It’s been an exciting year for UKI2S, with £37 million additional capital into the fund,…
CEO of PreSymptom Health Extensive commercialisation experience, and a history of entrepreneurship, including the…
Oliver Sexton, Investment Director at UKI2S Which styles of leadership work well and which don’t?…
Comment from the UKI2S investment team Funding early-stage technology companies is critical for turning innovation…
• ST80-HTS will achieve a higher sustained triple product¹ than any previous device •…
About Lineat: Lineat is reducing the carbon footprint of composite materials (carbon fibre) by…
Surrey University spin-out company raises £1.5M in a seed round led by UKI2S…
NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global…
In April 2021, HM Treasury published a new report (‘Getting smarter: a strategy for…
Three-year project backed by the Scottish Government and industry will develop and test fully…
25, July 2022 – The UK Innovation and Science Seed Fund (“UKI2S”) today announced the…
Oxford Space Systems (OSS) and Surrey Satellite Technology Ltd (SSTL) have completed the build…
CHAIN announces the appointment of Dr Matthew Duchars as Chief Executive from the 1st of…
About Jon Rees and MitoRx Therapeutics: • MitoRx is a preclinical research stage biotechnology…
Nemesis Bioscience Ltd announced today that it has been awarded a European Innovation Council (EIC)…
OXFORD, United Kingdom, July 14, 2022 – Mirico announced today that it had raised £2m…
Nemesis Bioscience Ltd announced today that it had appointed Dr Yoshinori Yamano to its board…
Andy Muir – Investment Director at UKI2S Alexander Leigh – Investment Director at UKI2S…
CHAIN announces a new collaboration with clinical researchers at the University of Oxford to develop…
Insights from Richard Anderson, Managing Partner at Sciad Communications. About Richard: Managing Partner at Sciad…
Out of academia and into business What is Mirico’s business? The main market that…
Zentraxa are excited to announce capital investment from Future Planet Capital, Bristol Private Equity…
Insights from Guy Levy-Yurista, PhD – CEO of Synthace. About Guy: CEO of Synthace,…
Steve Bennington, CEO of Q5D, speaks to UKI2S about his journey in science ventures and…
Appoints Industry Veteran Glyn Edwards MBE as Chair Oxford, England, 25 April 2022 – MitoRx…
In 2010, UKI2S made a £25,000 pathfinder investment in Tokamak Energy, a spin-out from the…
Coventry, United Kingdom, 10th March 2022 / Sciad Newswire / NanoSyrinx, a biotech company using engineering biology approaches…
Oxford, UK, 1 March 2022 / HydRegen, the revolutionary bioscience company, enables sustainable chemical manufacturing…
OXFORD, United Kingdom, 1st March 2022 – Mirico is collaborating with partners in the agricultural sector to baseline…
Q5D Technology is excited to announce a $2.5m seed investment in order to take its…
Oxford Space Systems (OSS) has announced an investment round, subject to final completion, of approximately…
Inobrodib is the first drug to target p300/CBP, a new way to treat specific cancers. Following…
A year of global challenges emphasises the role of science and technology in our changing…
Helix develops antennas that enable precision global network synchronisation and safe roll-out of autonomous vehicles…
Keith Thompson is the current chair of biotech start-up NK:IO. He’s also chair of the…
With the Global Methane Pledge launched at COP26 and new regulation being developed to…
Harwell, UK, 11th November 2021 / Atheras Analytics, a UK-based company in the satellite telecommunications…
Founded by Gilad Gershon and Dr Eyal Maori, Tropic Biosciences uses cutting-edge technologies to…
UKI2S Chair, Andrew Mackintosh In the lead up to COP26, Andrew Mackintosh, the newly appointed…
The Electrospinning Company (ESC) was established in 2010 as a spin-out by the UK Science…
Oxford University Spinout, Quantum Dice, announces the completion of its pre-seed fundraise, where…
UKI2S is proud to invest in innovative early-stage companies, helping them to commercialise their research.
Vector Photonics is a spin-out from the University of Glasgow, based on world-leading semiconductor research…
Medical technology company Presymptom Health has successfully closed its seed round funding to support the…
By John Sinden, CEO of Glialign Drug discovery and development has never been more of…
London, UK, 19th July 2021 / The UK Innovation and Science Seed Fund (UKI2S) is…
Coventry, UK, 19th July 2021 / NanoSyrinx, a biotech company developing a new cell engineering…
Jonathan Wogel, Executive Chairman of UKI2S portfolio company Zentraxa, has a career of two…
Powered by Cytox’s genoSCORE, the new test enables physicians to support patients with lifestyle changes,…
London, UK, 21st June 2021 – UKRI has provided a £10million funding boost to the…
17 June 2021, Oxford, UK – Tokamak Energy’s new high tech divertor lab has…
Against the challenging backdrop of a global pandemic, 2020 saw the successful merger of UKI2S…
2021 is set to be an interesting year for gene editing. Gene therapy research…
Harwell, UK, 4th May 2021 – The Electrospinning Company (Electrospinning), a leader in the development…
Harwell, Oxford, UK, 21st…
Vector Photonics has received £1.6m of equity investment to commercialise its unique, PCSEL-based, semiconductor laser…
London, UK, 8th April 2021 / Future Planet Capital (FPC) has announced its acquisition of…
The UK is at the forefront of fusion energy research and development, hosting the EU’s…
Our ‘CEO Spotlight’ series seeks to recognise the wide range of diverse innovators we work…
, a discovery-stage biotech company developing the next generation of cell therapies to treat cancer,…
Perfectus Biomed is delighted to announce the appointment of Dr Lloyd Payne to the…
The UK materials manufacturing sector turns over £33.5bn per year, comparable to the aerospace sector…
Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to…
The second round of funding will enable the company to commence the development of…
In recognition of wide range of diverse innovators we work with and support, we are…
Cambridge and Newcastle, UK, 06 January 2021 – Atelerix Ltd (Atelerix) announces the appointment…
Harwell, Oxford, UK December 17th 2020 MIRICO Limited today announced that it has acquired…
Author: Ian Taylor MBE Introduction The past year has highlighted the importance of scientific…
Not every journey reaches its intended destination or takes the expected path en route to…
Coventry, UK, 10th December 2020 / NanoSyrinx announces the appointment of Dr Jane Dancer to…
At the UK Innovation and Science Seed Fund (UKI2S), we recognise the importance of supporting…
Completing a UK/US merger can be a complicated and demanding undertaking at the best of…
R&D in the UK is thriving and extraordinary innovation can be found in all sectors,…
Company presentation & partnering opportunities now available online Ikarovec, which is developing novel gene…
NanoSyrinx is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and protein delivery…
UK Innovation and Science Seed Fund (UKI2S) portfolio company, AgPlus Diagnostics, has been awarded…
Funding will be used to explore scalable methods of human cell preservation, transport, and re-presentation…
The Smarter Food Company has raised £1m in funding to accelerate the development of food…
In our latest guest blog, Antoine Espinet, Founder and CEO of MicrofluidX, shares…
Jim Naismith is Founder and Technical Director of GyreOx, a biotechnology…
announced today that it had reached an agreement on terms for a two-year research collaboration…
The UK Innovation and Science Seed Fund (UKI2S) is delighted to announce the collaboration of …
In the current global climate, many people – and businesses – are struggling. On both…
UKI2S Accelerator funding leverages recent investment & advances pipeline Ikarovec, which is developing novel…
Perfectus Biomed Limited are excited to officially announce that our merger with Wyoming based…
In our latest guest blog, Dr Carolyn Porter, CEO of CytoSeek, shares her experiences…
Atelerix is a biotechnology company providing an innovative solution for storing and transporting cells and…
Tim Bestwick shares his insights on the opportunities and challenges for startups in the fusion…
In a recent article for OBN’s CONNECT magazine, UKI2S provides its insights into early…
London, UK, 20th April 2020 / MicrofluidX announces it has raised £1.4m in seed funding…
Guest blog for UKI2S by Richard Anderson, Managing Partner, Sciad Communications As the COVID-19 pandemic…
30th March 2020, London: The UK Innovation and Science Seed Fund (UKI2S) has published…
11 March 2020: GyreOx Therapeutics (GyreOx), developing its novel MACRO platform, has launched today with backing…
Barbara Domayne-Hayman is an expert in supporting early stage companies in the UK life sciences…
Founded by UK Innovation & Science Seed Fund (UKI2S) with co-investment from LifeArc & Parkwalk…
Key challenges faced and solutions implemented when spinning out a company Starting a company will…
11th December, 2019, Alderley Park: UK Innovation & Science Seed Fund (UKI2S),…
At this year’s Genesis Conference, Oliver Sexton, Investment Director at UKI2S, will be…
Written by Vernon Hunte, Associate Director, AprilSix Proof 27 November 2019 With the General…
25 November 2019 A University of Bristol spin-out company has raised £1.1 million in funding…
25 November 2019: University of Birmingham spinout Linear Diagnostics Ltd has raised £2m to…
The success of the UK in starting and growing biotech companies is well known, but…
November 18th 2019 — Cambridge and Newcastle, UK – Atelerix, pioneers in the storage and…
London, UK, 8th November 2019: UK Innovation & Science Seed Fund (UKI2S) is delighted…
Despite so much political and economic uncertainty, the UK life sciences start-up sector continues…
Companies have raised over 6x more investment thanks to grant funding. London, UK, 21, October…
C-Major Medical, a medical device product development company based at Sci-Tech Daresbury, using its…
FOR DEVELOPMENT OF NEW CLASS OF ANTIBIOTICS TO COMBAT LIFE-THREATENING DRUG-RESISTANT PATHOGENS Stevenage, UK,…
Having saved millions of lives across the planet, antibiotics are beginning to fail us: indiscriminate…
Cambridge and Newcastle, UK, 21st August 2019: Atelerix, pioneers in the storage and transport of…
Small companies are better than big businesses at maintaining a culture of innovation. David Lawrence…
After a busy year so far, the summer lull is the time for a much-needed…
SynbiCITE, the UK’s national centre for the commercialisation of engineering biology, is powering the…
Oliver Sexton, Investment Director, and Pablo Lubroth, Investment Manager, UKI2S, share their thoughts on the…
Engineering technology innovators Oxford Flow and Utonomy are testing new products to improve the gas…
The UK is good at research, but poor at innovation. That’s a common view among…
UKI2S would like to congratulate CytoSeek on winning the Rising Star Award at the 1st…
14th June 2019 / UKI2S, a leading early-stage venture capital fund facilitating the growth…
Innovative software company Synthace is working to transform the way that scientists and companies do…
21st May 2019 – London — The £27m UK Innovation & Science Seed Fund…
Cell encapsulation for transport of cells and tissues at room temperature 9th May 2019 —…
MARLOW & NOTTINGHAM, UK. — April 8, 2019 – UK microbiome therapeutics company CHAIN Biotechnology…
Cambridge, UK, 21 March 2019 – Crescendo Biologics Ltd (Crescendo), the drug…
The DNA alphabet just doubled in size. Steven Benner at the Foundation for Applied…
Funding for 75 Centres for Doctoral Training (CDTs) under the umbrella of the Engineering…
Eagle Genomics closes $3.5M investment, led by the Environmental Technologies Fund Investment to enable Eagle’s…
Artificial Intelligence, or machine learning, is steadily working its way into our lives. Businesses are…
The relationship between human health and the microbes that live on and within us (our…
The BioCentury China Healthcare Summit saw thought leaders from industry, academia and finance meet…
Headlines: CRISPR Ethics. Life Science Sector Deal Announced. CRISPR: Chinese research scientist, Dr He…
UKI2S has privileged access to emerging research across many of the UK’s science and…
Nuclear fusion has long held the promise of cheap, plentiful and, above all, clean energy…
Synbio Digest features news, views and reports covering the engineering biology industry and recent research.
UKI2S announced in August the successful exit of its portfolio company…
Read the full press release here:- https://blog.eaglegenomics.com/microsoft-genomics-ventures-into-the-microbiome-with-eagle-genomics …
The world’s most popular fruit is facing extinction, and scientists are racing to use gene-editing…
Eagle Genomics has landed a prestigious co-sell partnership with Microsoft for their knowledge…
Cambridge, UK, 11 September 2018 – Crescendo Biologics Ltd (Crescendo), the drug developer of…
Co-sell partnership to provide unparalleled access to Microsoft’s Enterprise customers Eagle Genomics solution enables…
Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program…
UK Innovation & Science Seed Fund (UKI2S) and Imperial Innovations announce the launch of Cagen,…
UKI2S biotech company CellCentric, University of Cambridge spinout, has raised $26m to fund…
Recognised by Leading Analyst Firm for its Laboratory of the Future Platform LONDON 19 June…
Banana plantations in Australia, south-east Asia, Africa and the Middle East have been ravaged…
May 15th 2018 CellCentric has raised $26 million in private financing to fund clinical…
We work closely with our partner laboratories to identify commercial opportunities arising from their world-class…
London, 2nd May 2018 The UCL Technology Fund (UCLTF), UK Innovation &…
Software leader in the field of genomic data and bioinformatics analysis poised for growth 30…
Cell encapsulation start-up enables the shipment of human cells at room temperature, overcoming problems of…
STFC spin-out pioneering new generation of laser gas-sensing solutions 30 April 2018 – Oxford —…
26/03/2018 Three leading British biotechnology businesses have obtained grant funding from Innovate UK to…
Production of CCS1477 in capsule form is now complete, ahead of forthcoming first-in-human clinical…
The UK Innovation & Science Seed Fund (UKI2S) – formerly known as Rainbow…
First science companies funded from investment accelerator pilot that joins grant funding with venture capital…
In recognition of our Fund’s widening reach to build world-leading companies from world-leading UK science,…
UK Innovation & Science Seed Fund is a patient capital investor…
A Smart Textiles Technology Developed at the National Physical Laboratory…
UK Innovation & Science Seed Fund has closed its first investment (to be announced…
Investing in the UK life science ecosystem In a further acknowledgement of how important the…
Eco-friendly engineering biology start-up revolutionising dyeing process Early-stage investor UK Innovation & Science Seed…
Chemical detection innovator secures access to global markets Early-stage investor UK Innovation &…
As you may have read in our Chairman Ian Taylor’s recent blog “For…
UKI2S portfolio update: New investments in Linear Diagnostics & Nemesis Bioscience + significant advancements for…
With the increasing presence in our lives of robotics, artificial intelligence, genomics and a host…
Spinout developing novel hand-held reader to help in the fight against antibiotic resistance…
Quethera, a biopharmaceutical company developing therapies for…
Nemesis Bioscience today announced the successful completion of its latest funding round, bringing total seed…
May 03, 2017 Justin Petrone www.genomeweb.com British molecular diagnostics company…
UK Innovation & Science Seed Fund is partnering with…
UK Innovation & Science Seed Fund is proud to sponsor the UK’s first Engineering Biology…
Researchers looking into retinitis pigmentosa have been able to improve vision in rats using the…
Plants get damaged by the sun just like people, and they protect themselves from sun…
IBioIC Innovation & Investment – Glasgow On 26 January 2017, UKI2S Investment Manager Oliver…
Scientists in China have become the first in the world to administer CRISPR-Cas9-edited cells to…
— Early-stage venture fund key in bridging gap between UK research and commercialisation — Fund…
Alaska Airlines and the Washington State University-led Northwest Advanced Renewables Alliance (NARA)…
CellCentric is developing first in class drug compounds against a key regulator of cancer.
Two UKI2S portfolio companies recognised amongst world’s most innovative companies UKI2S companies Tokamak Energy and…
On 2 November in Manchester, UKI2S Investment Director Mark White will speak on the …
Collaboration to generate tumor targeting drug conjugates and immuno-oncology therapeutics Crescendo Biologics Limited (Crescendo),…
SynbiCITE and UK Innovation & Science Seed Fund today announce that Sir Richard…
Mark White, BA, MBA, is Midven’s investment director and is an…
On 11 October in London, UK Innovation & Science Seed Fund Investment Director…
AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics UK…
Sciad Newswire / SynbiCITE and UK Innovation & Science Seed Fund today announce that…
Andrew Muir, PhD, is a director at Midven, and leads the UK Innovation…
CRISPR-Cas9 is a precise and targeted technique for genome editing that allows even a…
Oliver Sexton, MSc, is Midven’s investment director and manager of UK Innovation &…
Midven’s UK Innovation & Science Seed Fund, along with SynbiCITE, a…
Today marks the launch of Bio-start, an annual competition designed to bolster…
In May 2016, the publication of Lord Jim O’Neill’s…
Following the completion of the sequencing of the entire human genome in…
Following the creation of the world’s first synthetic cell, Mycoplasma mycoides JCVI-syn1.0 in 2010, researchers…
Mineral resources are vital to a growing and increasingly urbanized global population. They’re also critical…
On 29 June, Dr Andrew Muir, UK Innovation & Science Seed Fund’s Investment Director…
Weight loss drug developer Symmetry Therapeutics has done it. Anti-infectives company ANTABIO has…
Berlin, Germany, 25th May 2016 – The winner of the Start-up Battle, a pitching competition…
Prepare for your next financing round or growth phase by catching up with the box…
This week we’re announcing our most recent investment – we are funding Mirico, an…
Spin out from UK publicly-funded research develops novel laser spectroscopy for environmental, medical diagnosis and…
Contego, a UK software company providing cloud-based identity verification and fraud solutions, has…
Synthace Ltd., a London based technology company developing Antha, a high level language and operating…
The Minister for Life Sciences George Freeman MP has launched the UK Engineering Biology…
Imagine a city lit by cool to touch, wireless, low carbon lighting.
Quethera Ltd, a privately funded gene therapy company based at the Babraham Research Campus…
Cambridge, UK: 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and…
January 7th, 2016 — Contego announces today that it is part of the…
Don’t Confuse Election Issues With Economic Issues…
The AquAdvantage salmon, a fast-growing salmon from AquaBounty Technologies, has become the…
Antibody veteran joins new CEO as Crescendo redirects strategy to Oncology focus…
Many companies set their sights on the large and lucrative US market, and those developing…
Crescendo Biologics Limited, the drug discovery and developer of Humabody™ VH therapeutics, has…
Participation will aid comparison of SNP genotyping with biomarker status Cytox…
Read the thoughts of Chris Martin Non Executive Directors on the UKI2S Seed Advisory…
Synthace and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company…
UK Innovation & Science Seed Fund, the UK government-backed fund dedicated to…
A group of UK research organisations, including the Wellcome Trust, have confirmed…
Desktop Genetics Ltd (“DTG” or “the Com pany”), a UK bioinformatics company aiming to…
Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven’s UK Innovation & Science Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.
The cross-disciplinary field of engineering biology allows scientists to design and engineer…
The Institution of Mechanical Engineers’ £2mn Stephenson Fund to invest in innovative companies working in…
Oxford Space Systems (OSS) has successfully secured £1.2m in its second round fund raise…
World Economic Forum today announced its selection of the world’s 49 most promising Technology Pioneers…
20 July 2015: Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment…
ITER, the international fusion reactor being built in France, will stand 10 stories tall,…
Combining excellence in industrial biotechnology May 18th, 2015 – Welwyn Garden City, UK and…
One of the most satisfying things about working with early stage biotech ventures…
Much of the focus in the recent Budget has been around George Osborne’s…
Synthetic biology is arguably the enabling technology of the post-silicon age, and…
Daresbury Science and Innovation Campus Sci-Tech Daresbury (the Daresbury Science…
One of the UK’s most innovative venture capital funds is to partner with two leading…
Spectral Edge, a start up funded by the UK Innovation…
At up to £60 a cup, kopi luwak is one…
The Norwich Research Park, based in East Anglia, is one of the UK Innovation &…
Synthetic biology is a new and exciting cross-disciplinary field that combines…
Engineering Biology Companies Are Coming of Age…
Creating a new technology company is an exciting time. It is an opportunity to get…
When we talk about the tech revolution that is currently sweeping the industrialised…
Having just returned from a technology conference in the US where I mingled with tech…
Innovation Here, Expanding Overseas…
Fund Adds Life Science Commercialisation Expert Oliver Sexton to Investment Team and Renewables Entrepreneur Sean…
18 July 2014 – Spectral Edge announces today the completion of a £300K financing…
Midven’s Chairman Brian Blakemore, a leading financial expert with a career spanning 40 years…
Parts of our planet are so hostile they are unreachable. But if we are to…
The West Midlands – Proud To Be UK’s Hub…
London has been lauded as the centre of the startup universe, but is…
The West Midlands Is Well Used To Being Dubbed “The Centre” Of The Country. New…
Dragons’ Den’s panel of would-be investors may have adopted a…
Next stage for ‘risk-taking’ public sector, early-stage technology investment fund British technology investor…
VH domains are the smallest, most robust antibody fragments and as such have advantages for…
I think I’ve reached the age that I can now begin a blog by saying…
6 November 2013 Entrepreneurial scientists in the engineering biology space can benefit from a new…
Entrepreneurial scientists in the engineering biology space can benefit from a new £10M investment fund…
Contego Fraud Solutions, the rapidly growing Oxfordshire-based risk management software company, has announced that they…
It’s a question we’ve been pondering due to the fact that so many small innovative…
Eagle Genomics (Eagle), an expert provider of bioinformatics software and services across a wide range…
New investment coupled with a major award from the UK’s innovation agency, the Technology Strategy…
KEIT Ltd is a brand new, forward thinking spin out company from the Science and…
A Company which offers bespoke microbiological testing has secured £100,000 investment. Perfectus Biomed, based at…
Suitable for low temperatures and high vibrations, immune to EMI Reduces system weight and…
Tim Grasby recently joined Midven as an investment manager to develop its relationship with Harwell…
At a recent event for our portfolio companies which provided a forum for discussion and…
Midven Investment Manager Giovanni Finocchio has extensive sales and marketing experience within the SME environment,…
Midven Annual Review 2013…
The path of raising finance for the entrepreneur is always a precarious balancing act. As…
Cambridge, UK. 16th January 2013 – Crescendo Biologics Limited (Crescendo) today announces the Crescendo Mouse,…
Hot on the heels of yet another Midven portfolio company securing an award…
November 29, 2012: ProKyma, a spin-out from the Defence Science and Technology Laboratory (Dstl),…
GEOSCIENCE BUSINESS RECEIVES FUNDING BOOST Nottingham-based BGS International, which spun out from the British Geological…
Everywhere you look at the moment is risk, whether it be political, economic or financial,…
NicOx enters into option agreement to acquire Altacor as a first step towards building an…
Tue, 17/01/2012 – 12:26 Cobalt Light Systems has received European approval for its revolutionary INSIGHT100…
Novacta Biosystems has commenced dosing of the first healthy volunteers in a phase 1 clinical…
Just one drop of liquid can destroy your phone or tablet! Acting like a barrier,…
Cambridge, UK. 22 June 2011 – Crescendo Biologics Limited (Crescendo) today announces the appointment of…
UK. 12 October 2009 – Mike Romanos has been appointed Chief Scientific Officer of Crescendo…
This is a image+text block
Potential 4 Column Gallery
Image with optional caption and formatted text side by side on desktop and stacking on mobile. Easily to be used for editorial content. Can be quickly adapted for more controlled layout options with fixed image ratios.
